- Home
- ACTG vs HUMA Comparison
ACTG vs HUMA Comparison
Compare ACTG & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- HUMA
- Stock Information
- Founded
- ACTG 1993
- HUMA 2004
- Country
- ACTG United States
- HUMA United States
- Employees
- ACTG 1036
- HUMA N/A
- Industry
- ACTG Multi-Sector Companies
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ACTG Miscellaneous
- HUMA Health Care
- Exchange
- ACTG Nasdaq
- HUMA Nasdaq
- Market Cap
- ACTG 314.4M
- HUMA 356.8M
- IPO Year
- ACTG 1996
- HUMA N/A
- Fundamental
- Price
- ACTG $3.34
- HUMA $1.58
- Analyst Decision
- ACTG
- HUMA Strong Buy
- Analyst Count
- ACTG 0
- HUMA 7
- Target Price
- ACTG N/A
- HUMA $11.93
- AVG Volume (30 Days)
- ACTG 234.8K
- HUMA 6.2M
- Earning Date
- ACTG 08-06-2025
- HUMA 08-11-2025
- Dividend Yield
- ACTG N/A
- HUMA N/A
- EPS Growth
- ACTG N/A
- HUMA N/A
- EPS
- ACTG N/A
- HUMA N/A
- Revenue
- ACTG $247,813,000.00
- HUMA $818,000.00
- Revenue This Year
- ACTG $141.36
- HUMA N/A
- Revenue Next Year
- ACTG N/A
- HUMA $936.09
- P/E Ratio
- ACTG N/A
- HUMA N/A
- Revenue Growth
- ACTG 62.44
- HUMA N/A
- 52 Week Low
- ACTG $2.70
- HUMA $1.15
- 52 Week High
- ACTG $5.36
- HUMA $7.48
- Technical
- Relative Strength Index (RSI)
- ACTG 43.82
- HUMA 34.06
- Support Level
- ACTG $3.17
- HUMA $1.47
- Resistance Level
- ACTG $3.50
- HUMA $2.02
- Average True Range (ATR)
- ACTG 0.15
- HUMA 0.21
- MACD
- ACTG -0.00
- HUMA -0.06
- Stochastic Oscillator
- ACTG 38.60
- HUMA 8.56
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.